Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (271-280 of 4,674) with videos related to

Pageof 468
Sort By:
Cancer Discovery|May 2, 2022
Gender Equity in Science and Medicine: Breaking the ImpasseJennifer R Grandis
Cancer Discovery|May 2, 2022
Adapted to Survive: Targeting Cancer Cells with BH3 MimeticsJoan Montero, Rizwan Haq
Cancer Discovery|May 2, 2022
Tryptophan-to-Phenylalanine Codon Reassignment Induces Immunoreactivity
Cancer Discovery|May 2, 2022
Dual Temozolomide and ICI Treatment Is Efficacious and Safe in MSS mCRC
Cancer Discovery|May 2, 2022
Ruxolitinib with Navitoclax Is Efficacious and Safe in Myelofibrosis
Cancer Discovery|May 2, 2022
Coblockade of TIGIT and PD-1 Optimizes Antitumor CD8+ T-cell Response
Cancer Discovery|May 2, 2022
Perturb-map Enables Identification of Genetic Regulators of the TME
Cancer Discovery|May 2, 2022
Pembrolizumab Is Safe and Effective in Kaposi Sarcoma
Cancer Discovery|May 2, 2022
Colorectal Cancer Genomics by Genetic AncestryCathy Eng, Andreana N Holowatyj
Cancer Discovery|June 19, 2019
Going After <i>MET</i>ex14 in NSCLC
Pageof 468

Showing results (271-280 of 4,674) with videos related to

Sort By:
Pageof 468
Cancer Discovery|May 2, 2022
Gender Equity in Science and Medicine: Breaking the ImpasseJennifer R Grandis
Cancer Discovery|May 2, 2022
Adapted to Survive: Targeting Cancer Cells with BH3 MimeticsJoan Montero, Rizwan Haq
Cancer Discovery|May 2, 2022
Tryptophan-to-Phenylalanine Codon Reassignment Induces Immunoreactivity
Cancer Discovery|May 2, 2022
Dual Temozolomide and ICI Treatment Is Efficacious and Safe in MSS mCRC
Cancer Discovery|May 2, 2022
Ruxolitinib with Navitoclax Is Efficacious and Safe in Myelofibrosis
Cancer Discovery|May 2, 2022
Coblockade of TIGIT and PD-1 Optimizes Antitumor CD8+ T-cell Response
Cancer Discovery|May 2, 2022
Perturb-map Enables Identification of Genetic Regulators of the TME
Cancer Discovery|May 2, 2022
Pembrolizumab Is Safe and Effective in Kaposi Sarcoma
Cancer Discovery|May 2, 2022
Colorectal Cancer Genomics by Genetic AncestryCathy Eng, Andreana N Holowatyj
Cancer Discovery|June 19, 2019
Going After <i>MET</i>ex14 in NSCLC
Pageof 468